Late and very late drug-eluting stent malapposition serial 2-year quantitative IVUS analysis

Circulation: Cardiovascular Interventions

Volumn 3, Issue 4, 2010, Pages 335-340

  Kang, Soo Jin ^a   Mintz, Gary S ^b   Park, Duk Woo ^a   Lee, Seung Whan ^a   Kim, Young Hak ^c   Lee, Cheol Whan ^a   Han, Ki Hoon ^a   Kim, Jae Joong ^a   Park, Seong Wook ^a   Park, Seung Jung ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^c Asan Medical Center   (South Korea)

Author keywords

Drug eluting stent; Late stent malapposition; Volumetric IVUS analysis

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIAC PATIENT; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG ELUTING STENT; ELASTICITY; ENDOPROSTHESIS LOOSENING; FEMALE; FOLLOW UP; HEART DEATH; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; MALE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STENT MALAPPOSITION; STENT THROMBOSIS;

ADULT; CORONARY ARTERY DISEASE; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; ULTRASONOGRAPHY, INTERVENTIONAL; WOUND HEALING;

EID: 78650116798     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.109.916502     Document Type: Article

References (14)

1. Hong MK, Mintz GS, Lee CW, Kim YH, Lee SW, Song JM, Han KH, Kang DH, Song JK, Kim JJ, Park SW, Park SJ. Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation. Circulation. 2004;109:881-886. (Pubitemid 38252740)
2. Mintz GS, Shah VM, Weissman NJ. Regional remodeling as the cause of late stent malapposition. Circulation. 2003;107:2660-2663. (Pubitemid 36667237)
3. Shah VM, Mintz GS, Apple S, Weissman NJ. Background incidence of late malapposition after bare-metal stent implantation. Circulation. 2002; 106:1753-1755.
4. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, Van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadDen E, Lansky A, Hamon M, Krucoff MW, Serruys PW; Academic Research Consortium. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation. 2007;115:2344-2351. (Pubitemid 46685903)
5. Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB III, Loop FD, Peterson KL, Reeves TJ, Williams DO, Winters WL Jr. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation. 1988;78:486-502.
6. Popma JJ, Leon MB, Moses JW, Holmes DR Jr, Cox N, Fitzpatrick M, Douglas J, Lambert C, Mooney M, Yakubov S, Kuntz RE; SIRIUS Investigators. Quantitative assessment of angiographic restenosis after sirolimuseluting stent implantation in native coronary arteries. Circulation. 2004;110: 3773-3780. (Pubitemid 40023975)
7. Ellis SG, Popma JJ, Lasala JM, Koglin JJ, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Stone GW. Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: Analysis from the TAXUS-IV trial. J Am Coll Cardiol. 2005;45:1193-1200. (Pubitemid 40523136)
8. Lee SW, Park SW, Kim YH, Yun SC, Park DW, Lee CW, Hong MK, Rhee KS, Chae JK, Ko JK, Park JH, Lee JH, Choi SW, Jeong JO, Seong IW, Cho YH, Lee NH, Kim JH, Chun KJ, Kim HS, Park SJ. A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus. J Am Coll Cardiol. 2008;52: 727-733.
9. Park SJ, Shim WH, Ho DS, Raizner AE, Park SW, Hong MK, Lee CW, Choi D, Jang Y, Lam R, Weissman NJ, Mintz GS. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med. 2003;348: 1537-1545. (Pubitemid 36437930)
10. Mintz GS, Weissman NJ, Teirstein PS, Ellis SG, Waksman R, Russo RJ, Moussa I, Tripuraneni P, Jani S, Kobayashi Y, Giorgianni JA, Pappas C, Kuntz RA, Moses J, Leon MB. Effect of intracoronary gamma-radiation therapy on in-stent restenosis: An intravascular ultrasound analysis from the GAMMA-1 study. Circulation. 2000;102:2915-2918.
11. Hong MK, Mintz GS, Lee CW, Park DW, Park KM, Lee BK, Kim YH, Song JM, Han KH, Kang DH, Cheong SS, Song JK, Kim JJ, Park SW, Park SJ. Late stent malapposition after drug-eluting stent implantation: An intravascular ultrasound analysis with long-term follow-up. Circulation. 2006;113:414-419. (Pubitemid 43803203)
12. Degertekin M, Serruys PW, Tanabe K, Lee CH, Sousa JE, Colombo A, Morice MC, Ligthart JM, de Feyter PJ. Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: An intravascular ultrasound analysis. Circulation. 2003;108:2747-2750. (Pubitemid 37498975)
13. Aoki J, Colombo A, Dudek D, Banning AP, Drzewiecki J, Zmudka K, Schiele F, Russell ME, Koglin J, Serruys PW; TAXUS II Study Group. Peristent remodeling and neointimal suppression 2 years after polymerbased, paclitaxel-eluting stent implantation: Insights from serial intravascular ultrasound analysis in the TAXUS II study. Circulation. 2005; 112:3876-3883. (Pubitemid 43739485)
14. Hong MK, Mintz GS, Lee CW, Park DW, Lee SW, Kim YH, Kang DH, Cheong SS, Song JK, Kim JJ, Park SW, Park SJ. Impact of late drugeluting stent malapposition on 3-year clinical events. J Am Coll Cardiol. 2007;50:1515-1516. (Pubitemid 47494599)